文献速递主动脉疾病

破裂性与择期EVAR术后内漏发生率及转归差异

The incidence and fate of endoleaks vary between ruptured and elective endovascular abdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-03-06

研究比较2002至2013年166例破裂性(r-EVAR)与1886例择期(e-EVAR)肾下腹主动脉瘤EVAR患者,随访平均30个月。r-EVAR组II型内漏发生率显著低于e-EVAR(9.0% vs 20.2%,P<.01),I型内漏发生率相近,但r-EVAR组支架移植物取出更频繁(5.4% vs 1.1%,P<.01)。

要点

  • r-EVAR组II型内漏发生率显著低于e-EVAR组(9.0% vs 20.2%)。
  • 两组I型内漏发生率相似,但r-EVAR组支架取出率更高(5.4% vs 1.1%)。
  • 两组二次干预需求相当,经皮栓塞趋势无统计学差异。

核心结论

  • 与e-EVAR相比,r-EVAR患者I型内漏发生率相似,II型内漏发生率显著更低。
  • r-EVAR合并I型或II型内漏患者支架移植物取出风险显著更高。

研究设计与样本

  • 回顾性分析2002至2013年2052例肾下腹主动脉瘤EVAR患者,其中r-EVAR 166例(8.1%),e-EVAR 1886例(91.9%)。
  • 随访包括术后1个月、6个月及每年CT血管造影,数据前瞻性录入血管数据库。

主要发现

  • 平均随访30个月,r-EVAR组II型内漏发生率9.0%(15例),e-EVAR组20.2%(380例),P<.01。
  • r-EVAR组I型内漏发生率5.4%(9例),e-EVAR组4.4%(83例),P=.68。
  • r-EVAR组支架移植物取出率5.4%(9例),e-EVAR组1.1%(20例),P<.01。
  • 二次干预需求r-EVAR组19.9%(33例),e-EVAR组23.3%(439例),P=.37。
  • 经皮栓塞治疗r-EVAR组6.6%(11例),e-EVAR组11.5%(216例),P=.06。

关键数值与推荐

  • 所有I型和III型内漏在诊断时或诊断后不久接受治疗。
  • EVAR术后6个月以上持续II型内漏且瘤囊未缩小者行经腰椎或经股动脉栓塞术。

临床怎么用

  • r-EVAR术后内漏可多数经腔内手段处理,但需警惕I型或II型内漏患者支架取出风险更高。
  • 对r-EVAR术后内漏应密切随访,及时干预持续性内漏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of ruptured abdominal aortic aneurysm (r-AAA) patients who are treated by endovascular means is increasing as ruptured endovascular aneurysm repair (r-EVAR) enters the mainstream. However, even today, data on the incidence and behavior of endoleaks after r-EVAR are scarce. This study analyzed whether endoleaks behave differently after EVAR for rupture vs elective AAA repair. METHODS: From 2002 to 2013, there were 2052 patients who underwent EVAR for treatment of rupture (n = 166 [8.1%]) and elective repair (n = 1886 [91.9%]) of infrarenal AAA. Follow-up included computed tomography angiography at 1 month, at 6 months, and yearly thereafter. All type I and type III endoleaks were treated at the time of or shortly after the diagnosis. Persistent type II endoleaks at >6 months after EVAR without a decrease in AAA sac underwent translumbar or transfemoral embolization procedures. Data were prospectively collected in a vascular database. RESULTS: During a mean follow-up of 30 months, patients had a significantly lower incidence of type II endoleaks after r-EVAR compared with elective endovascular aneurysm repair (e-EVAR; n = 15 [9.0%] vs n = 380 [20.2%]; P < .01). Although the incidence of type I endoleaks is similar after r-EVAR (n = 9 [5.4%] and e-EVAR (n = 83 [4.4%]; P = .68), the r-EVAR patients required stent graft explantation more frequently (n = 9 [5.4%] vs n = 20 [1.1%]; P < .01). Whereas the need for secondary intervention was comparable in both r-EVAR (n = 33 [19.9%]) and e-EVAR (n = 439 [23.3%]; P = .37) groups, patients undergoing percutaneous embolization procedures trended toward significance between the two groups (n = 11 [6.6%] vs n = 216 [11.5%]; P = .06) with endoleaks. CONCLUSIONS: Compared with e-EVAR, patients who undergo r-EVAR experience a similar incidence of type I endoleaks and a significantly lower incidence of type II endoleaks. The endoleaks in both e-EVAR and r-EVAR patients can frequently be managed by endovascular means. However, r-EVAR patients with type I and type II endoleaks are at a significantly higher risk for stent graft explantation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Quinn AA, Mehta M, Teymouri MJ, et al. The incidence and fate of endoleaks vary between ruptured and elective endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28268109. doi:10.1016/j.jvs.2016.10.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。